Health Care

CVS Health (NYSE: CVS) on Wednesday reported fourth-quarter financial results that were stronger than what analysts had anticipated. The company…

-- Exact Sciences Corp. (NASDAQ: EXAS) reported Q4 2019 earnings of $0.54 per share, vs. a loss of $0.35 expected.…

--  Palatin Technologies, Inc. (NYSE: PTN) reported a loss of $0.02 per share in the second quarter of 2020, vs $0.01 per…

-- Aethlon Medical (NASDAQ: AEMD) reported third quarter 2020 net loss attributable to company of $820,000 or $0.28 per share…

Allergan plc (NYSE: AGN), which is all set to be acquired by rival drugmaker AbbVie (ABBV), reported a 21% increase…

The pharmacy retail market is witnessing a major transformation, with traditional drugstore operators adopting technology to keep pace with their…

AbbVie (NYSE: ABBV) topped revenue and earnings expectations for the fourth quarter of 2019, allowing the stock to gain over…

With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the…

-- Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the…

-- Sanofi (NASDAQ: SNY) reported net loss of EUR 10 million or EUR 0.01 per share for the fourth quarter…

-- Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected. --…

Bristol-Myers Squibb Company (NYSE: BMY) slipped to a loss in the fourth quarter of 2019 from a profit last year,…

-- Regeneron Pharmaceuticals (NASDAQ: REGN) reported Q4 2019 earnings of $7.50 per share, vs. $6.92 expected. -- Revenues grew 13%…

-- Cigna Corporation (NYSE: CI) reported Q4 2019 earnings of $4.31 per share, vs. $4.20 expected. -- Revenues totaled $$38…

After closing the high-value acquisition of Celgene a few months ago, Bristol-Myers Squib (NYSE: BMY) will be publishing its fourth-quarter…

Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings for the fourth quarter of 2019. However, the company's…

--  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected.…

-- Humana Inc. (NYSE: HUM) reported its fourth-quarter 2019 adjusted earnings of $2.28 per share versus $2.20 per share expected.…

Biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) reported a decline in fourth-quarter earnings, despite a modest increase in revenues. Earnings…

-- McKesson Corporation (NYSE: MCK) reported its third-quarter 2020 adjusted earnings of $3.81 per share versus $3.56 per share expected.…

--  Centene Corporation (NYSE: CNC) reported earnings of $0.73 per share in the fourth-quarter 2019, in line with Wall Street expectation.  --…